• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Imclone Systems

Imclone Systems

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Verastem Reports Year-End 2016 Financial Results

    Verastem Reports Year-End 2016 Financial Results

  2. eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation

    eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation

  3. Carl Icahn Takes Stake in Bristol-Myers Squibb -- 2nd Update

    Carl Icahn Takes Stake in Bristol-Myers Squibb -- 2nd Update

  4. New Pressure on Drug Giant -- WSJ

    New Pressure on Drug Giant -- WSJ

  5. The Infallible Trading System

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  6. Reinvent Your Practice: Alternatives to Traditional Succession Planning

    Following is a roundup of stocks that recently jumped to 5 stars in the last week. By way of background, we award a stock 5 stars when it trades at a suitably large discount--i.e., a margin of safety--to our fair value estimate. Thus, when a stock hits 5-star territory, we consider it an especially ...

©2017 Morningstar Advisor. All right reserved.